Akums Drugs and Pharmaceuticals informs about updates

26 Nov 2024 Evaluate
Akums Drugs and Pharmaceuticals has informed that Maxcure Nutravedics (Maxcure), a wholly owned subsidiary of Akums Drugs and Pharmaceuticals (Akums) has entered into a Collaboration Agreement with Jagdale Industries (Jagdale). This collaboration exclusively focuses on aseptic manufacturing and subsequent filling in carton packing for the Ready-to-Drink (RTD) market, targeting an expansive array of health and wellness products.

The above information is a part of company’s filings submitted to BSE.


Akums Drugs & Pharma Share Price

447.75 1.20 (0.27%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×